We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$525B
AUM Growth
+$91.7B
Cap. Flow
+$84.3B
Cap. Flow %
16.06%
Top 10 Hldgs %
21.31%
Holding
3,738
New
263
Increased
2,391
Reduced
822
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 10.66%
3 Healthcare 9.68%
4 Consumer Discretionary 8.35%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYAI icon
3576
Dyadic International
DYAI
$38.6M
$24.2K ﹤0.01%
16,336
MLSS icon
3577
Milestone Scientific
MLSS
$33.3M
$23.5K ﹤0.01%
34,400
BMTX
3578
DELISTED
BM Technologies, Inc.
BMTX
$23K ﹤0.01%
10,210
RJET
3579
Republic Airways Holdings
RJET
$845M
$22K ﹤0.01%
859
APYX icon
3580
Apyx Medical
APYX
$162M
$21.8K ﹤0.01%
16,288
+3,800
+30% +$5.61K
PXLW icon
3581
Pixelworks
PXLW
$37.2M
$21.6K ﹤0.01%
1,830
HOOK
3582
DELISTED
HOOKIPA Pharma
HOOK
$21.5K ﹤0.01%
3,641
+12
+0.3% +$95
CLIR icon
3583
ClearSign Technologies
CLIR
$25.4M
$21.3K ﹤0.01%
2,556
CUE icon
3584
Cue Biopharma
CUE
$118M
$21.2K ﹤0.01%
569
-2,482
-81% -$123K
RCAT icon
3585
Red Cat Holdings
RCAT
$1.03B
$21.2K ﹤0.01%
18,398
JOB icon
3586
GEE Group
JOB
$22.8M
$20.4K ﹤0.01%
66,522
UAMY icon
3587
United States Antimony
UAMY
$728M
$19.9K ﹤0.01%
59,275
IMA
3588
ImageneBio Inc
IMA
$63.4M
$19.9K ﹤0.01%
1,006
-6,156
-86% -$109K
CGTX icon
3589
Cognition Therapeutics
CGTX
$80.6M
$19.9K ﹤0.01%
11,965
RAVE icon
3590
RAVE Restaurant Group
RAVE
$42.8M
$19.8K ﹤0.01%
10,013
+1
+0% +$2
SLS icon
3591
SELLAS Life Sciences
SLS
$1.99B
$19.3K ﹤0.01%
16,238
CVM icon
3592
CEL-SCI Corp
CVM
$19.9M
$19.1K ﹤0.01%
549
BNGO icon
3593
Bionano Genomics
BNGO
$12.5M
$19K ﹤0.01%
467
OESX icon
3594
Orion Energy Systems
OESX
$38.9M
$18.9K ﹤0.01%
1,699
HYFM icon
3595
Hydrofarm Holdings
HYFM
$2.66M
$18.7K ﹤0.01%
2,715
VOR icon
3596
Vor Biopharma
VOR
$1.06B
$17.8K ﹤0.01%
890
-4,306
-83% -$139K
WWR icon
3597
Westwater Resources
WWR
$49.7M
$16.6K ﹤0.01%
34,475
SKYX icon
3598
SKYX Platforms
SKYX
$143M
$16K ﹤0.01%
16,813
-147,033
-90% -$144K
NXTC icon
3599
NextCure
NXTC
$20.4M
$15.9K ﹤0.01%
833
BNKK
3600
Bonk Inc
BNKK
$7.7M
$15.7K ﹤0.01%
386

Similar funds

Charles Schwab's Q2 2024 Portfolio in Review

As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.

  • Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
  • Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
  • Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
  • Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
  • Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
  • Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
  • Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.